Año: 2022
Journal Impact Factor (JIF): 4.80
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 65/278 | Q1 | T1 | D3 |
| INFECTIOUS DISEASES | SCIE | 35/96 | Q2 | T2 | D4 |
Año: 2022
Journal Citation Indicator (JCI): 0,980
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 34/129 | Q2 | T1 | D3 | 74,03 |
| PHARMACOLOGY & PHARMACY | 91/366 | Q1 | T1 | D3 | 75,27 |
Año:
2022
CiteScore:
5,500
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 10/79 | Q1 | T1 | D2 |
| Pharmacology (medical) | 79/260 | Q2 | T1 | D4 |
| Infectious Diseases | 109/304 | Q2 | T2 | D4 |
| Biochemistry | 205/428 | Q2 | T2 | D5 |
| Microbiology | 79/163 | Q2 | T2 | D5 |
| Microbiology (medical) | 50/124 | Q2 | T2 | D5 |
SJR año:
2022
Factor de Impacto:
0,792
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 13/117 | Q1 | T1 | D2 |
| Pharmacology (medical) | 81/282 | Q2 | T1 | D3 |
| Biochemistry | 164/454 | Q2 | T2 | D4 |
| Infectious Diseases | 123/341 | Q2 | T2 | D4 |
| Microbiology | 64/178 | Q2 | T2 | D4 |
| Microbiology (medical) | 51/137 | Q2 | T2 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| Instituto de Salud Carlos III | REIPI RD16/0016/0001; PI19/01645; FI17/00235; CM20/0092 |
| # | Autor |
|---|---|
| 1 | Ortiz-Padilla, Miriam |
| 2 | Portillo-Calderón, Inés |
| 3 | Velázquez-Escudero, Ana |
| 4 | Rodríguez-Baño, Jesús |
| 5 | Pascual, Álvaro |
| 6 | |
| 7 |